Chimeric Antigen Receptor T-Cell Therapy in Acute Myeloid Leukemia – Targeted Oncology
|
Chimeric Antigen Receptor T–Cell Therapy in Acute Myeloid Leukemia
Targeted Oncology Chimeric antigen receptor (CAR) T-cell therapy is a novel form of cellular immunotherapy in which autologous T cells are genetically modified to express CARs found on tumor cells, as well as on costimulatory molecules required for T-cell activation … |
